CENTAUR PHARMS PVT
GenericsCENTAUR PHARMS PVT is a generic drug manufacturer focused on Neurology.
CENTAUR PHARMS PVT's Key Drugs
CENTAUR PHARMS PVT's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
CENTAUR PHARMS PVT's Recent FDA Approvals
New NDA/BLA approvals for CENTAUR PHARMS PVT over the last two years — novel drugs only, excluding generics and label supplements.
CENTAUR PHARMS PVT's Therapeutic Areas
CENTAUR PHARMS PVT's approved drugs and pipeline span 1 therapeutic area, led by Neurology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
CENTAUR PHARMS PVT's Top Competitors
CENTAUR PHARMS PVT's closest competitors by therapeutic-area and drug-target overlap include Pfizer, AbbVie, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
CENTAUR PHARMS PVT Pipeline Snapshot
Active clinical trials for CENTAUR PHARMS PVT across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Neurology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2026-02-23
- Latest
- 2026-02-23
- Applications
- 1